Terminé
A phase IIb, noncomparative, open-label, randomized trial evaluating the efficacy and tolerability of three first-line antiretroviral regimens, combining tenofovir-emtricitabine or lamivudine with zidovudine, or with lopinavir/ritonavir or raltegravir, in adults infected with HIV-2 in West Africa
A randomized, noncomparative, Phase IIb, open-label trial evaluating the efficacy and tolerability of three first-line antiretroviral regimens, combining tenofovir-emtricitabine or lamivudine with zidovudine, or with lopinavir/ritonavir or raltegravir, in adults infected with HIV-2 in West Africa
Project Details
Description & Context
A randomized, noncomparative, Phase IIb, open-label trial evaluating the efficacy and tolerability of three first-line antiretroviral regimens, combining tenofovir-emtricitabine or lamivudine with zidovudine, or with lopinavir/ritonavir or raltegravir, in adults infected with HIV-2 in West Africa
Research Team
The research team has not yet been filled in for this project.
Collaborate with us
We are open to partnerships with international research institutions and doctoral students.
Research Request
Estimated response time: 3-5 business days.
Keywords
OUR PROJECTS
